Research Article
A Network Pharmacology-Based Approach to Investigate the Novel TCM Formula against Huntington’s Disease and Validated by Support Vector Machine Model
Table 10
The connection of potential TCM formula and HD.
| Origin TCM | Compounds | Targets |
| Brucea javanica | flazine | CK2A2 | | azelaic acid | CK2A2 | | bruceine F | CK2A2 | | azelaic acid | STK3 | | bruceine F | STK3 | Dichroa febrifuga | Febrifugine | CK2A2 | | Febrifugine | mtHSP70 | | A-Dichroine | STK3 | | β-Dichroine | STK3 | | Febrifugine | STK3 | E. micranthum Harms | Cassaidine | mtHSP70 | | Cassaine | mtHSP70 | Erythrophleum guineense | Cassaidine | mtHSP70 | | Cassaine | mtHSP70 | Holarrhena antidysenterica | Holantosine A | mtHSP70 | | Holantosine C | mtHSP70 | | Holantosine D | mtHSP70 | Japanese Ardisia Herb | 2,2′-[Benzene-1,4-diylbis(methanediyl- oxybenzene-4,1-diyl)]bis(oxoacetic acid) | CK2A2 | | 2,2′-[Benzene-1,4-diylbis(methanediyl- oxybenzene-4,1-diyl)]bis(oxoacetic acid) | STK3 | Taraxacum formosanum | (+)-Taraxafolin B | CK2A2 | | (+)-Taraxafolin B | LATS1 | Typha angustifolia | Typhic Acid | CK2A2 | | Typhic Acid | STK3 |
|
|